Sujatha Kannan
3PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 12, 2026
Dendrimer-Conjugated Glutamine Antagonist, D-TTM020, Ameliorates Brain Immune Dysregulation and Improves Neurobehavioral Deficits in the Mecp2-Deficient Mouse Model.Preeti Vyas, Elizabeth Smith Khoury, Nirnath Sah
|Sep 30, 2023
Dendrimer nanotherapy targeting of glial dysfunction improves inflammation and neurobehavioral phenotype in adult female Mecp2-heterozygous mouse model of Rett syndrome.Elizabeth Smith Khoury, Ruchit V Patel, Caroline O'Ferrall
|Jul 20, 2022
Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial.Aaron M Gusdon, Nauder Faraday, John S Aita
Pageof 1
Frequent Collaborators
2 joint publications
Nirnath Sah
1 joint publications
Aaron M Gusdon
1 joint publications
John S Aita
1 joint publications
Sunil Kumar
1 joint publications
Ishan Mehta
1 joint publications
Jeffery L Cleland
1 joint publications
Keith Robinson
1 joint publications
Louise D McCullough
1 joint publications
Rangaramanujam M Kannan
1 joint publications
Susanna Scafidi
